N eoadjuvant chemoradiotheraphy (CRT) improves tumor downstaging, pathological complete response (pCR), and local control (1, 2). pCR rates of 13%-30% have been reported in phase II and phase III trials following 5-fluorouracil-based preoperative CRT (3, 4). Currently, management of patients with clinical complete response (cCR) remains controversial (5-8).
PURPOSE
We aimed to prospectively determine if analyzing pre-and post-chemoradiotheraphy (CRT) changes in the signal intensity (SI) and apperent diffusion coefficient (ADC) values from diffusion-weighted magnetic resonance imaging (DW-MRI) can accurately predict complete responders for locally advanced rectal cancer.
MATERIALS AND METHODS
Thirty patients (mean age, 54.3 years) with locally advanced rectal cancer who underwent neoadjuvant CRT and subsequent surgery were included in this study. All patients were evaluated pre-and post-CRT by standardized turbo spin echo and DW-MRI. Pre-and post-CRT tumor and normal rectal wall SI (which were gradually scored as very high, high, intermediate, low, and no signal) and ADC values were recorded.
RESULTS
Tumor SIs were decreased in all of the patients that had a therapy response. However, complete tumor SI loss was only seen in two (22.2%) of nine patients with a pathological complete response, while it regressed to low and/or intermediate SI levels in the remaining seven patients (77.8%). Post-CRT ADC values of rectal tumors were significantly higher from the pre-CRT ADC values (P < 0.0001; Z=-9.39). However, post-CRT ADC values from the complete and partial/no response patient groups were not significantly different (P = 0.071; Z=-1.99).
CONCLUSION
In re-staging of rectal tumors by DW-MRI, an increase in ADC values and decrease in SIs can predict therapy response but cannot unequivocally determine a complete response.
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Standard TSE pelvic MRI protocol
The T1-weighted MR sequence was performed in the transverse plane, and the first T2-weighted MR sequence was performed in the sagittal plane. The sagittal images were then used to help plan the thin-slice transverse and coronal T2-weighted images (Table  1) . The tranverse and coronal oblique images were obtained orthogonal and parallel to the long axis of the rectum. All sequences were obtained with no fat saturation. The patients did not receive intravenous (IV) gadolinium or antiperistaltic agents.
The patients were asked to perform rectal cleaning 2-3 hours prior to the MRI using a fleet enema (133 mL; 19 g sodium phosphate monobasic and 7 g sodium phosphate dibasic; CB Fleet Co. Inc., Lynchburg, Virginia, USA). Warm water was administered with a balloon-tipped rectal tube while the patient was in the MRI suite, and the rectum was filled until the patient felt full. The volume of water ranged from 150 to 400 mL. The rectal tube was removed after instillation.
TSE-MRI interpretation
Pre-CRT diagnostic criteria for the T3 stage included extention of the tumor through the muscle layer into perirectal fat with obliteration of the interface between muscle and perirectal fat (17) . Morphologic criteria for positive lymph nodes were greater than 3 mm in size, mixed signal intensity, irregular margins, and a shape that was spherical rather than ovoid or flat (18) .
DW-MRI protocol
DW images were obtained in the axial plane using a multisection singleshot inversion recovery echo planary sequence (IR-EPI) and b-values of 50, 400, and 800 s/mm² without breathholding (Table 1) . Images with a bvalue of 800 s/mm² were used for the evaluation.
DW-MRI interpretation
All images were reviewed on a picture archiving and communication system workstation monitor by two gastrointestinal system radiologists (G.E., R.S.), each with at least three years of clinical experience interpreting rectal MRI. The images were analyzed by consensus between the two reviewers. Both radiologists were blinded to information obtained either at the time of surgery or the pathological analysis reviewed from pre-and post-CRT DW-MRI. For qualitative information, tumor SI was scored as very high, high, intermediate, low, or no signal, according to the normal rectal wall on the b-800 value images. The light bulb appearance was considered to be a very high signal. For quantitative analysis, rectal wall with a normal apprearance and rectal tumor ADC values were recorded from three regions of interest on the ADC mapping images by using dedicated software at the workstation. The measurements from the three regions of interest were averaged. A circular region of interest of at least 4 mm 2 (larger than 2 mm in minimum diameter) was placed within three sections of the tumor to obtain average ADC values of the heterogeneous tumor.
After CRT, a decrease or absence of SI and increase of ADC values in the tumor were considered to represent a good therapeutic response. CR was predefined as an unidentified mass or wall thickening without any identifiable residual tumor SI. These findings were correlated with pathological results after surgery.
(≥T3 and/or lymph node positive) rectal cancer based on pre-CRT MRI and/ or endorectal ultrasonography were prospectively included in this study. The patients were confirmed to have rectal cancers without metastatic disease based on an endoscopic colonoscopy. This study was approved by the local research and ethics committee, and informed consent was obtained from each patient before participation.
MRI technique
All patients underwent a pre-CRT MRI for primary tumor staging and a second, restaging MRI for response evaluation six weeks after completion of CRT. Distant metastasis analysis was conducted with thoracal computed tomography (CT) and abdominal CT or MRI. The median time between the second MRI and surgery was 15 days (range, 14-17 days).
MRI studies were performed using a 1.5 Tesla MRI (Symhony, Siemens Medical Solutions, Erlangen, Germany) system and a four-element body phased-array coil, before and after neoadjuvant CRT. Standart pelvic turbo spin echo (TSE) and DW-MRI techniques were used. Intersection gap (mm)
Parallel imaging factor
Partial fourier factor ----6/8
Band length (Hz per pixel)
TSE, turbo spin echo; T1W, T1-weighted; T2W, T2-weighted; STIR, short time inversion recovery; DW, diffusion-weighted; FOV, field of view; TR, repetition time; TE, echo time; EPI, echo planar imaging; NSA, number of signal averages.
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Neoadjuvant CRT protocol
Preoperative radiation therapy (RT) was applied using the three planes technique (postero-anterior and two lateral regions) with 45 Gy per 25 fractions administered to the reference points over the course of 5-6 weeks. The rectal tumor, total mesorectum, common and internal iliac, and pelvic lymph nodes were included in the clinical target volume. The small bowels and bone marrow were sheltered with the collimator. A three-dimensional (3D) therapeutic planning system was used with the CT.
The patients received continuous IV injection of 5-fluorouracil (225 mg/m²) concurrent with RT. All patients waited eight weeks between the completion of neoadjuvant CRT and surgery.
Reference standard
Pathological staging served as the reference standard and was based on the TNM staging system and the Dworak tumor response grading system (19, 20) (Table 2) .
Statistical analysis
Statistical analysis was performed using a computer software (Statistical Package for Social Sciences version 10.0, SPSS Inc., Chicago, Illinois, USA). Pairwise comparison and agreement evaluation were calculated by nonparametric Wilcoxon test and Spearman's rho correlation coefficient with a 95% confidence level, respectively. R values of ≥0.75, 0.74-0.50, and <0.50 represent very good, good, and poor agreement, respectively. The Wilcoxon signed rank test was used to test the significance of the difference in tumor SI before and after CRT. The differences in pre-and post-CRT ADC values of normal rectal wall and rectal tumor were tested by Spearman's rho correlation coefficient and Wilcoxon signed rank test. Differences in tumor ADC values with CRT between pathological regression score (pRS) 4 and pRS 0-3 tumors were assessed by using the Wilcoxon signed rank test. The exact 95% confidence intervals (CIs) for these values were calculated with the assumption of a binomial distribution.
Results
Before adjuvant CRT, all rectal tumors were staged as T3 based on the TNM staging system. Three tumors were localized in the upper rectum, 18 tumors were in the middle rectum, and nine tumors were in the lower rectum. None of the patients had distant metastases.
Qualitative analysis
Before CRT, all rectal tumors, including two mucinous subtypes, showed SI between intermediate and very high levels on the b-800 value DW-MR images. In 27 (90%) of 30 rectal tumors, very high and high SIs were seen ( Table 3) . The tumor diffusion SI was significantly decreased in all of the patients that demonstrated a response to therapy (P < 0.001; Z=4.8) ( Table 4 and Fig. 1 ). In two patients with a mucinous subtype, the tumor diffusion SIs decreased from high to low or intermediate levels. However, complete loss of tumor diffusion SI was only seen in two (22.2%) of nine patients with a pCR, while it regressed to low (n=5) and/or intermediate (n=2) SI levels in the remaining seven patients (77.8%) ( Table 4 and Fig. 2) . In one patient with no CRT response, the SI regressed from intermediate to low. (Table 5 ). However, the post-CRT mean ADC values of rectal tumors were significantly higher than that of the pretreatment rectal tumor ADC values (P = 0.002; Z=-9.39) ( Table 5 , Figs. 1 and 2) . However, the mean ADC values of pRS 4 (n=9) and pRS 0-3 (n=21) were not statistically diffferent (P = 0.071; Z=-1.99; 95% CI, -34.09-0.49) ( Table 6) .
Surgical therapy
All patients recevied a total mesorectal excision eight weeks after neoadjuvant CRT. Based on the MRI findings, low anterior resection (n=19), abdominoperineal resection (n=8), proctectomy (n=2), or resectional biopy (n=1) was administered.
Pathological findings after surgery
Upon pathological evaluation after surgery, 21 patients with residual rectal tumors were staged as T2 (n=7) or T3 (n=14). Two patients had a mucinous histopathologic subtype of tumor. The N staging results of all patients showed tumor staging of N0 (n=26), N1 (n=2), or N2 (n=2). The mean residual tumor volume was 4.5±7.0 cm 3 (range, 0.0-28.1 cm 3 ). Based on the Dworak tumor response grading system, the patient evaluation showed RS 0 in one patient, RS 1 in nine patients, RS 2 in eight patients, RS 3 in three patients, and RS 4 in nine patients.
Discussion
In this study, we prospectively investigated the efficiency of DW-MRI for the prediction of neoadjuvant therapy response in locally advanced rectal cancer. Although there is controversy regarding the necessity of aggressive surgery in patients with pCR after CRT (5-8), informing colorectal surgeons of an accurate tumor response to neoadjuvant CRT before surgery by using DW-MRI is beneficial for complete responders because they would benefit from less extensive resection, such as sphincter-preserving surgery. Our study focused on determining if complete responders can be accurately predicted by measuring pre-and post-CRT changes in the ADC values and SI. In previous studies of therapy response using DW-MRI as a method for evaluation, changes in ADC values were described; however, in this study, we also analyzed SI changes.
A number of previous studies have shown that bright SI or lower ADC values based on DW-MRI are associated with more viable tumor tissue, in which diffusion is more restricted because of intact cellular membranes (21-23). Ichikawa et al. (24) evaluated the usefulness of high-b-value DW-MRI with qualitative (SI) analyses for the detection of colorectal adenocarcinoma in 33 patients. According to their preliminary results, the mean sensitivity and specificity of high-bvalue DW-MRI for the detection of colorectal adenocarcinoma were 90.9% (30/33; 95% CI, 74.5%-97.6%) and 100% (15/15; 95% CI, 74.6%-100%), respectively. Similiarly, Rao et al. (25) proved the added value of DW-MRI imaging to conventional T2-weighted imaging in the detection of rectal cancer. In this study, all rectal tumors were visible before treatment and had higher SIs relative to the normal rectal wall on DW-MR images with b-800 values. Moreover, the SIs were very high or high in 27/30 (90%) of the rectal tumors.
Preliminary studies related to quantitative DW-MRI showed that ADC measurements may be able to differentiate the normal rectum from neoplastic involvement in addition to distinguishing inflammatory and neoplastic involvements. In a small retrospective series, ADC values of the normal rectum and rectosigmoid malignancy groups and rectosigmoid carcinoma and inflammatory bowel disease groups were significantly different (P < 0.01). A cut-off value for carcinomas of 1.14×10 -3 mm 2 /s yielded a sensitivity and specificity of 93.3% and 93.3%, respectively (26) . In a recent study, Song et al. (23) reported that the mean ADC of the viable tumor group was significantly lower than that of the non-viable tumor group. They concluded that adding DWI to T2-weighted imaging is helpful for detecting viable tumour after neoadjuvant CRT compared to T2-weighted imaging alone or to positron emission tomography (PET)/ CT in patients with locally advanced rectal cancer. In our current study, the pre-treatment mean ADC values of the normal rectal wall and rectal tumors were 1.70×10 -3 mm 2 /s (1.49-1.97 mm 2 /s) and 0.84×10 -3 mm 2 /s (0.61-1.25 mm 2 /s), respectively, which were statistically different (P < 0.001;
Z=4.62).
In recent years, there have only been a few, small, preliminary studies of the use of DW-MRI for evaluating pCR to neoadjuvant CRT (27) (28) (29) . In a recent, retrospective, multicenter trial, the added value of DW-MRI in the evaluation of pCR to neoadjuvant CRT was investigated in patients with 120 locally advanced rectal cancer. The sensitivity for the selection of complete responders ranged from 0% to 40% by standard MRI compared to 52%-64% with DW-MRI, and resulted in less overestimation of tumors in patients with a pCR after the addition of DW-MRI (14) . In the current study, tumor diffusion SIs were significantly decreased in all patients who had a response after CRT (P < 0.001; Z=4.8). However, the quantitative analysis on DW-MRI was not considered to be a reliable method for the differentiation of complete and partial responders, because scores of 1-2 level tumor SIs were still present in 77.8% of the patients with pCR.
Kim et al. (15) showed that adding DW-MRI to conventional MRI yields better diagnostic accuracy than the use of conventional MRI alone in the evaluation of CR to neoadjuvant CRT in patients with locally advanced rectal cancer. They stated that the mean ADC of the pCR group was significantly higher than that of the non-pCR group (1.62×10 -3 vs. 1.04×10 -3 mm 2 /s, respectively; P < 0.0001); however, an overlap of ADC values was observed in the two groups (15) . In the current study, ADC measurements were taken from the normal rectal wall and rectal tumors. While the ADC values of the normal rectal wall did not change (P = 0.09; Z=1.8) after CRT, the ADC values of the rectal tumors increased significantly (P < 0.0001; Z=-9.39). Unfortunately, there was no significant difference between ADC values of patients with pCR and partial response after neoadjuvant CRT (P = 0.071; Z=-1.99). This finding suggests that ADC values can not be used to accurately differentiate complete responders from partial responders.
Recently, Curvo-Semedo et al. (16) stated similar results in assessing pCR in patients with locally advanced rectal cancer after CRT and found that ADC measurements were not reliable for this purpose. It is believed that the presence of microscopic residual tumor cell nests in fibrotic areas or in the mucinous subset is the main reason for indiscrimination of CR from near CR by DW-MRI (15) . In our study, this hypothesis was supported by the determination that there was no relationship between post-CRT ADC values and SI changes with pRS in rectal tumors. Even with the recent technical advances in DW-MRI, the cellular heterogeneity of the tumor in response to neoadjuvant CRT cannot be overcome, because even high-spatial-resolution reconstructed ADC mapping based on minute voxels cannot be used to determine the tumor response at each individual cellular level (30) . Therefore, further studies of novel functional imaging modalities are needed to detect microscopic residual tumor cell nests. PET-CT has similiar limitations for identifying microscopic residual tumor cell nests besides the low spatial resolution and high cost. Currently, perfusion imaging represents one of the most interesting fields of CT development. This technique has shown promise in predicting the response to neoadjuvant treatment (31, 32) . Our study had several limitations. First, the size of the pCR patient group in this study was relatively small. Second, the images were analyzed by consensus between two reviewers, and therefore the interobserver variability of ADC measurements was not tested. Third, the limited spatial resolution and the relatively poor signalto-noise ratio of high b-value DW-MRI should be considered as a limitation. Therefore, it was impossible to identify detailed rectal wall layers on highb-value DW-MR images alone, as the background signal intensity was suppressed, especially in the normal rectal wall. Moreover, we used a high b-value of 800 s/mm 2 compared to 1000 s/mm 2 , and therefore it is possible that the sensitivity of this technique was decreased by the presence of patients with false-positive results (33, 34) .
In conclusion, for the re-staging of rectal tumors by DW-MRI, an increase in ADC values and decrease in SIs can predict therapy response but cannot unequivocally determine a complete response. Therefore, further studies of novel functional imaging modalities are needed to identify microscopic residual tumor cell nests.
